Halladay Jason S, Wong Susan, Jaffer Sharmin M, Sinhababu Achintya K, Khojasteh-Bakht S Cyrus
Department of Drug Metabolism and Pharmacokinetics (MS 70), Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, USA.
Drug Metab Lett. 2007 Jan;1(1):67-72. doi: 10.2174/187231207779814364.
In vitro metabolic stability assays are used to screen compounds for stability in the presence of various drug metabolizing enzymes, usually cytochrome P450 in liver preparations (e.g., liver microsomes). High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage. In our laboratory, we have improved the metabolic stability assay using the cassette analysis method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compound throughput, and maximizes mass spectrometer usage. This method can determine metabolic stability using microsomes or hepatocytes from any species. We describe our findings following incubation of 40 different compounds with human liver microsomes and analysis by the cassette and discrete analysis methods. Similar metabolic stability results were obtained using the cassette analysis and discrete analysis method. An overall 70% time savings was achieved by pooling four new compounds into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the number of injections on LC/MS/MS analysis, and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS analysis time.
体外代谢稳定性测定用于筛选化合物在各种药物代谢酶存在下的稳定性,这些酶通常存在于肝脏制剂(如肝微粒体)中的细胞色素P450。为了跟上先导药物吸收、分布、代谢和排泄(ADME)优化阶段的筛选要求,已经开发了使用合并方法的高通量代谢稳定性测定。在我们实验室,我们改进了使用盒式分析法、柱切换的代谢稳定性测定,并在方法开发中采用了节省时间的技术,以产生一种强大的方法,该方法可减少数据周转时间、提高化合物通量并最大限度地使用质谱仪。该方法可以使用来自任何物种的微粒体或肝细胞来测定代谢稳定性。我们描述了40种不同化合物与人肝微粒体孵育后,通过盒式分析和离散分析方法进行分析的结果。使用盒式分析和离散分析方法获得了相似的代谢稳定性结果。通过将四种新化合物合并到一个样品中进行方法开发/质谱优化、将四个样品合并到一个样品中以尽量减少液相色谱/串联质谱(LC/MS/MS)分析中的进样次数以及使用柱切换系统分析样品,总体节省了70%的时间,这使得LC/MS/MS分析时间减少了一半。